Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Darragh Halpenny

Complete Pathological Response to Crizotinib in a Patient With ALK-rearranged Lung Adenocarcinoma

Clinical Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2020English

Computed Tomographic Features Predictive of Local Recurrence in Patients With Early Stage Lung Cancer Treated With Stereotactic Body Radiation Therapy

Clinical Imaging
Nuclear MedicineRadiologyImaging
2015English

Related publications

A Novel EML6-ALK FBXO11-ALK Double Fusion Variant in Lung Adenocarcinoma and Response to Crizotinib

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Dramatic Response to Crizotinib in an ALK-Positive Adenocarcinoma Patient With Disseminated Intravascular Coagulation

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2013English

A Case of ALK- Rearranged Adenocarcinoma With Small Cell Carcinoma-Like Transformation and Resistance to Crizotinib

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

A Dramatic Response to Crizotinib in a Non–Small-Cell Lung Cancer Patient With IHC-Positive and FISH-Negative ALK

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2012English

P071 Variants Distribution and Heterogeneity of Outcomes to Crizotinib in ALK-Rearranged Chinese Non-Small Cell Lung Cancers

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Miliary Brain Metastases in a Patient With ROS1-Rearranged Lung Adenocarcinoma: A Case Report

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2014English

P1.01-58 Variants Distribution and Heterogeneity of Outcomes to Crizotinib in ALK-Rearranged Chinese Non-Small Cell Lung Cancers

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.01-53 Local Treatment for Oligoprogression/Oligometastases After Failure to Crizotinib for ALK-Rearranged Stage IV Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P121 Clinical Value of Local Therapy in Advanced Crizotinib-Treated ALK-Rearranged Lung Cancer: Pattern of Failure Analyses

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy